Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Pharmacology

• Publication date

  2005-03-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPHAR.2005.01.010PMID 15740719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory Effect of Barusiban and Atosiban on Oxytocin-Induced Contractions of Myometrium From Preterm and Term Pregnant Women

  2004cited by this paper
• Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

  2003cited by this paper
• FE 200 440: a selective oxytocin antagonist on the term‐pregnant human uterus

  2003cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor.

  2002cited by this paper
• Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.

  2001cited by this paper
• The oxytocin receptor system: structure, function, and regulation.

  2001cited by this paper
• Direct Identification of Human Oxytocin Receptor-binding Domains Using a Photoactivatable Cyclic Peptide Antagonist

  2001cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

  1999cited by this paper
• Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis.

  1999cited by this paper
• Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation.

  1998cited by this paper
• The role of N-terminal glycosylation in the human oxytocin receptor.

  1997cited by this paper
• Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor*

  1996cited by this paper
• Advances in the design of selective antagonists, potential tocolytics, and radioiodinated ligands for oxytocin receptors.

  1995cited by this paper
• An extracellular residue determines the agonist specificity of V2 vasopressin receptors

  1995cited by this paper
• Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.

  1993cited by this paper
• 125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.

  1988cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Increasing cervical penetrability in sheep by long-acting treatments with oxytocin (Carbetocin) and/or prostaglandin E2 (Dinoprostone).

  2025cites this paper
• Increasing matrix metalloproteinase-2 activity by treatment of ovine cervical explants with a long-acting analogue of oxytocin (Carbetocin) at the expected time of artificial insemination

  2025cites this paper
• In vitro study of carbetocin, an oxytocin receptor agonist, and 4-phenylfuroxan-3-carbonitrile, a NO-releasing agent, as cervical dilatators in sheep.

  2025cites this paper
• Carbetocin versus combination of oxytocin and ergometirne for the preventional of post-partum hemorrhage following cesarean section

  2022cites this paper
• Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists

  2020cites this paper
• Barusiban, a selective oxytocin receptor antagonist: placental transfer in rabbit, monkey, and human†

  2020cites this paper
• Pharmacokinetics and bioavailability of carbetocin after intravenous and intramuscular administration in cows and gilts.

  2019cites this paper
• Cyclic Peptide Design

  2019cites this paper
• Oxytocin/vasopressin-like peptide inotocin regulates cuticular hydrocarbon synthesis and water balancing in ants

  2019cites this paper
• Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism

  2019cites this paper
• Design of Oxytocin Analogs.

  2019cites this paper
• Oxytocin in metabolic homeostasis: implications for obesity and diabetes management

  2018cites this paper
• The Oxytocin Receptor: From Intracellular Signaling to Behavior.

  2018cites this paper
• Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.

  2018cites this paper
• Long-scale molecular dynamics simulations of cyclic peptide hormones vasopressin, urotensin and analogues

  2017cites this paper
• Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β‐Arrestin‐Independent Internalisation

  2016cites this paper
• Comparative study between effect of carbetocin and oxytocin on isoflurane-induced uterine hypotonia in twin pregnancy patients undergoing cesarean section

  2016cites this paper
• Social Hormones and Human Behavior: What Do We Know and Where Do We Go from Here

  2015cites this paper
• Hemostatic effect and postoperative benefits of intramyometrial carbetocin injection during myomectomy: a randomized controlled trial

  2015cites this paper
• New, potent, and selective peptidic oxytocin receptor agonists.

  2014cites this paper
• Oxytocinergic regulation of endogenous as well as drug-induced mood.

  2014cites this paper
• FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines

  2014cites this paper
• Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

  2013cites this paper
• Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat

  2012cites this paper
• Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors.

  2012cites this paper
• Cholesterol-induced conformational changes in the oxytocin receptor.

  2011cites this paper
• Are Females More Sensitive to MDMA-Related Discriminative Stimuli?

  2011cites this paper
• Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes*

  2011cites this paper
• Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat

  2011cites this paper
• Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.

  2010cites this paper
• Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test

  2010cites this paper
• [Evaluation of carbetocin (pabal) efficacy in the prevention of the postpartum hemorrhage in women after cesarean section--preliminary report].

  2009cites this paper
• Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists.

  2009cites this paper
• The evaluation of the efficacy of carbetocin (Pabal) in the prevention of the postpartum haemorrhage among women undergoing emergency cesarean section – the preliminary report

  2009influential citation
• Role of oxytocin/oxytocin receptor system in regulation of cell growth and neoplastic processes.

  2009cites this paper
• Oxytocin receptor ligands: a survey of the patent literature

  2008cites this paper
• Oxytocin receptors: ligand binding, signalling and cholesterol dependence.

  2008cites this paper
• The present and future of tocolysis

  2007cites this paper
• Preterm labour. The present and future of tocolysis.

  2007cites this paper
• Modeling the human oxytocin receptor for drug discovery efforts

  2007cites this paper
• Oxytocin Antagonists and Agonists

  2006cites this paper
• Carbetocin versus combination of oxytocin and ergometirne for Carbetocin versus combination of oxytocin and ergometirne for the preventional of post-partum hemorrhage following cesarean the preventional of post-partum hemorrhage following cesarean section

  year unknowncites this paper
• Increasing matrix metalloproteinase-2 (MMP-2) activity by treatment of ovine cervical explants with a long-acting analogue of oxytocin (Carbetocin) at the expected time of arti�cial insemination.

  year unknowncites this paper
• Pericervical Tourniquet versus Intra Operative Carbetocin in Pericervical Tourniquet versus Intra Operative Carbetocin in Reducing Blood Loss in Myomectomy by Laparotomy Reducing Blood Loss in Myomectomy by Laparotomy

  year unknowncites this paper